Dacomitinib Anhydrous vs Trastuzumab

## Dacomitinib Anhydrous vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Dacomitinib Anhydrous** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Dacomitinib Anhydrous — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Dacomitinib Anhydrous — Small molecule; Trastuzumab — Antibody.